TAKEDA PHARMS USA FDA Approval NDA 022352

NDA 022352

TAKEDA PHARMS USA

FDA Drug Application

Application #022352

Documents

Letter2011-07-25
Letter2015-12-18
Label2010-05-07
Label2011-07-25
Label2015-12-31
Letter2009-08-06
Letter2010-05-06
Letter2011-07-25
Letter2014-08-15
Label2009-07-30
Label2011-07-25
Label2014-08-15
Review2010-02-17
Summary Review2010-02-17
Medication Guide2016-12-09
Letter2020-05-15
Label2020-05-18
Medication Guide2020-05-18

Application Sponsors

NDA 022352TAKEDA PHARMS USA

Marketing Status

Prescription001

Application Products

001TABLET;ORAL0.6MG1COLCRYSCOLCHICINE

FDA Submissions

TYPE 7; Type 7 - Drug Already Marketed without Approved NDAORIG1AP2009-07-29PRIORITY
LABELING; LabelingSUPPL4AP2010-04-29UNKNOWN
REMS; REMSSUPPL13AP2011-07-20N/A
LABELING; LabelingSUPPL14AP2011-07-20UNKNOWN
LABELING; LabelingSUPPL17AP2014-08-14UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL19AP2013-05-15PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL21AP2013-11-25PRIORITY
LABELING; LabelingSUPPL22AP2015-12-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL23AP2016-01-25PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL25AP2016-12-22STANDARD
LABELING; LabelingSUPPL26AP2020-05-14STANDARD

Submissions Property Types

ORIG1Null40
SUPPL4Null7
SUPPL13Null6
SUPPL14Null6
SUPPL17Null7
SUPPL19Null0
SUPPL21Null0
SUPPL22Null15
SUPPL23Null0
SUPPL26Null7

TE Codes

001PrescriptionAB

CDER Filings

TAKEDA PHARMS USA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 22352
            [companyName] => TAKEDA PHARMS USA
            [docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/022352s026lbl.pdf#page=25"]
            [products] => [{"drugName":"COLCRYS","activeIngredients":"COLCHICINE","strength":"0.6MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"05\/14\/2020","submission":"SUPPL-26","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/022352s026lbl.pdf\"}]","notes":""},{"actionDate":"12\/17\/2015","submission":"SUPPL-22","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/022352s022lbl.pdf\"}]","notes":""},{"actionDate":"08\/14\/2014","submission":"SUPPL-17","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/022352s017lbl.pdf\"}]","notes":""},{"actionDate":"07\/20\/2011","submission":"SUPPL-14","supplementCategories":"REMS-Modified","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/022352s013s014lbl.pdf\"}]","notes":""},{"actionDate":"07\/20\/2011","submission":"SUPPL-14","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/022352s013s014lbl.pdf\"}]","notes":""},{"actionDate":"07\/20\/2011","submission":"SUPPL-13","supplementCategories":"REMS-Assessment","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/022352s013s014lbl.pdf\"}]","notes":""},{"actionDate":"04\/29\/2010","submission":"SUPPL-4","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/022352s004lbl.pdf\"}]","notes":""},{"actionDate":"04\/29\/2010","submission":"SUPPL-4","supplementCategories":"REMS-Assessment","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/022352s004lbl.pdf\"}]","notes":""},{"actionDate":"04\/29\/2010","submission":"SUPPL-4","supplementCategories":"REMS-Proposal","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/022352s004lbl.pdf\"}]","notes":""},{"actionDate":"04\/29\/2010","submission":"SUPPL-4","supplementCategories":"REMS-Modified","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/022352s004lbl.pdf\"}]","notes":""},{"actionDate":"07\/29\/2009","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/022352lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"COLCRYS","submission":"COLCHICINE","actionType":"0.6MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2020-05-14
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.